T50 - the new treatment target for patients with chronic kidney disease


Pathological Calcifications are a major problem in many diseases, cause suffering and shorten human life.

We make the risk of calcification measurable in blood. This adds important diagnostic value and supports the optimization of therapies.

We develop and commercialize products to measure and manage calcification in humans. We work under an ISO 13485-certified quality management system. CALCISCON is located in Nidau, Switzerland.